11:47 AM EST - Medicago Inc. : announced the successful production of a Rotavirus VLP vaccine candidate comprising all four structural antigens of rotavirus (VP2, VP4, VP6 and VP7) using Medicago's plant-based manufacturing platform. Medicago Inc.
shares T.MDG are trading up $0.02 at $0.75.
